Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Implementing zero based budgeting strategies can empower families to take control of their finances. Discover ways to achieve your financial goals.
20,150 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
As Rocket Lab nears a pivotal earnings print, investors are quietly growing more bullish. This piece breaks down why ...
January delivered a painful wake-up call for Duolingo investors as the stock dropped sharply. This guide unpacks the ...
Netflix’s strategic shift sent a ripple through the market, highlighting how breakup fees and deal terms shape stream...
When geopolitics and supply chains collide, a single stock can surge. This article breaks down why rare earth stock s...
A stock that surged 49% in 2025 can still be tempting in 2026. This guide breaks down how to assess a semiconductor p...
Logan Finance rolls out a premium Open Road Elevated tier to serve high-net-worth borrowers with larger loan needs ou...
A legendary investor makes a bold AI move. He recently closed a position in a company famous for aggressive AI spend ...
Investors are weighing Oklo's unique nuclear energy model against a bumpy ride in its stock. This guide breaks down t...
Pfizer has been a market mover, but recent shifts in demand and patent timelines raise concerns. This guide breaks do...
As Enhabit prepares to report its first-quarter results, investors need a clear playbook. This guide breaks down what...
Palantir often looks pricey at first glance, but the real story may be hidden in growth engines and future contracts....